von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 271-274

  Nagashima, Yoji ^a   Miyagi, Yohei ^a   Udagawa, Kaori ^a   Taki, Atsuko ^a   Misugi, Kazuaki ^a   Sakai, Naoki ^a   Kondo, Keiich ^a   Kaneko, Shigeki ^a   Yao, Masahiro ^a   Shuin, Taro ^a,b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

In situ hybridization (ISH); RCC; Renal cell carcinoma; von Hippel Lindau (VHL) gene

Indexed keywords

ADULT; ARTICLE; CEREBELLUM TUMOR; CONTROLLED STUDY; EMBRYO; FETUS; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; BRAIN; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION; KIDNEY TUBULES, PROXIMAL; LIGASES; MALE; MICE; PROSTATE; PROTEINS; PURKINJE CELLS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 10544244175     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<271::AID-PATH664>3.0.CO;2-2     Document Type: Article

References (15)

1. Lauf F, Tory K, Granna J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320.
2. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res 1994; 54: 2852-2855.
3. Kanno H, Kondo K, Ito S, et al. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastoma. Cancer Res 1994; 54: 4845-4847.
4. Herman JG, Latif F, Weng Y, et al. Silencing of VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-9704.
5. Knudson A, Hethcote H, Brown B. Mutation and childhood cancer: a probabilistic model. Proc Natl Acad Sci USA 1975; 72: 5115-5120.
6. Duan DR, Humphrey JS, Chen DYT, et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivation mutation. Proc Natl Acad Sci USA 1995; 92: 6459-6463.
7. Duan DR, Pause A, Burgess WH, et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995; 269: 1402-1406.
8. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr. Tumor suppression by the human von Hippel-Lindau gene product. Nature Genet 1995; 1: 822-826.
9. Kesseler PM, Vasavada SP, Rackley RR, et al. Expression of the von Hipple-Lindau tumor suppressor gene VHL in human fetal kidney and during mouse embryogenesis. Mol Med 1995; 1: 457-466.
10. Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol 1988; 19: 1072-1079.
11. Wharley JM, Naglich J, Gelbert L, et al. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994: 55: 1092-1102.
12. Thoenes W, Stroekel St, Rumpelt H-J. Histopathology and classification of renal cell tumours (adenomas, oncocytomas and carcinomas): the basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986; 181: 125-143.
13. Van Adelsberg JS, Frank D. The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature. Nature Med 1995; 1: 359-364.
14. Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990; 346: 194-197.
15. Thoenes W, Stroekel St, Rumpelt HJ, Moll R. Cytomorphological typing of renal cell carcinoma - a new approach. Eur Urol 1990; 18: 6-9.